Fluoguide AS
STO:FLUO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Fluoguide AS
Free Cash Flow
Fluoguide AS
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fluoguide AS
STO:FLUO
|
Free Cash Flow
-kr37m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Free Cash Flow
kr1.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
4%
|
CAGR 10-Years
46%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Free Cash Flow
kr6.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Galecto Inc
NASDAQ:GLTO
|
Free Cash Flow
-$18.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Free Cash Flow
€45.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Free Cash Flow
kr1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
41%
|
|
Fluoguide AS
Glance View
FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.
See Also
What is Fluoguide AS's Free Cash Flow?
Free Cash Flow
-37m
DKK
Based on the financial report for Dec 31, 2025, Fluoguide AS's Free Cash Flow amounts to -37m DKK.
What is Fluoguide AS's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-33%
Over the last year, the Free Cash Flow growth was -23%. The average annual Free Cash Flow growth rates for Fluoguide AS have been 1% over the past three years , -33% over the past five years .
